Daniele Piovani

Assistant Professor

Medical Statistics
Assistant Professor


  • 2003–2009 Bachelor’s degree in Chemistry and Pharmaceutical Technologies(Laurea Magistrale, 5-year course),Faculty of Pharmacy, University of Bologna, Bologna, Italy.
  • 2009–2010 Master of Science (M.Sc.) in Clinical Research,University of Milan, Faculty of Medicine, Milan, Italy.
  • 2010–2018 Research Fellowship, Istituto di Ricerche Farmacologiche “Mario Negri”, Department of Public Health, Laboratory for Mother and Child Health, Pharmacoepidemiology    Unit, Milan, Italy.
  • 2014–2018 Ph.D. in Epidemiology,Open University, Walton Hall, Kents Hill, Milton Keynes, United Kingdom.Title: “Determinants of Drug Utilisation During Childhood

Present academic appointment

Assistant Professor of Medical Statistics (MED/01)

Academic background

  • 2018–2022 Post-doctoral Research Fellow in Medical Statistics   (Assegnista di Ricerca, art. 22, legge n. 240/2010),Department of Biomedical Sciences,Humanitas UniversityMilan, Italy.

Teaching appointments

  • 2020–2023 Integrated course: “Ricerca, Evidenza Scientifica e Sistemi di Valutazione& delle Attività Sanitarie”, for the Master Degree (Laurea Magistrale) in “Scienze   Infermieristiche ed Ostetriche”. (12 hours of teaching per academic year; SSD:  MED/01), Humanitas University, Milan, Italy.

Academic honors, awards and prices

  • Award for the study: “The procoagulant effect of COVID-19 on the thrombotic risk of patients with hip fractures” (in Greek language), by Tsantes et al. (including D. Piovani), Panhellenic Congress for the 90 years of the Greek Society of Microbiology, 28–30 January 2022, Athens, Greece.
  • Recognition for the study: “Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses” (first author D. Piovani) published in Gastroenterology (IF: 33.883). It was chosen by the Editors in chief to be part of the Continuing Medical Education for Readers program and to have accompanying CME exercises.
  • Recognition for the study: “Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy”, by Cecconi et al. (second and corresponding author D. Piovani). It was chosen by the Editors in chief of Journal of Clinical Medicine (IF: 4.964) as “Editor’s choice” for the particular interest and importance in the field.
  • The publication: “Compassionate use of remdesivir in COVID-19”, by Bonovas, S., Piovani, D. published on the New England Journal of Medicine 2020; 382:e101. (Impact factor: 176.079) was cited in a press release by “POLITICO” on the 22/05/2020.



Humanitas is a highly specialized Hospital, Research and Teaching Center. Built around centers for the prevention and treatment of cancer, cardiovascular, neurological and orthopedic disease – together with an Ophthalmic Center and a Fertility Center – Humanitas also operates a highly specialised Emergency Department.